Japan has approved ground-breaking stem cell treatments for Parkinson’s and severe heart failure, one of the manufacturers and media reports said yesterday, with the therapies expected to reach patients within months.
Sumitomo Pharma said it received the green light for the manufacture and sale of Amchepry, its Parkinson’s disease treatment that transplants stem cells into a patient’s brain.
Japan’s Ministry of Health, Labor and Welfare also gave the go-ahead to ReHeart, heart muscle sheets developed by Cuorips that could help form new blood vessels and restore heart function, media reports said.
The treatments could be on the market and rolled out to patients as early as this summer, reports said, citing the health ministry, becoming the world’s first commercially available medical products using induced pluripotent stem (iPS) cells.
Japanese scientist Shinya Yamanaka won the Nobel Prize in 2012 for his research into iPS, which have the potential to develop into any cell in the body.
“I hope this will bring relief to patients not only in Japan but around the world,” Japanese Minister of Health, Labor and Welfare Kenichiro Ueno said. “We will promptly carry out all necessary procedures to ensure it reaches all patients without fail.”
In a statement, Sumitomo Pharma said it had obtained “conditional and time-limited approval” for the manufacture and marketing of Amchepry under a system which is reportedly designed to get these products to patients as quickly as possible.
The approval is a kind of “provisional license,” the Asahi Shimbun said, after the safety and efficacy of the treatment was judged based on data from fewer patients than in ordinary clinical trials for drugs.
A trial led by Kyoto University researchers indicated that the company’s treatment was safe and successful in improving symptoms.
The study involved seven Parkinson’s patients aged between 50 and 69, with each receiving a total of either 5 million or 10 million cells implanted on both sides of the brain. The iPS cells from healthy donors were developed into the precursors of dopamine-producing brain cells, which are no longer present in people with Parkinson’s disease.
The patients were monitored for two years and no major adverse effects were found, the study said.
Four patients showed improvements in symptoms.
Parkinson’s disease is a chronic, degenerative neurological disorder that affects the body’s motor system, often causing shaking and other difficulties in movement.
Worldwide, about 10 million people have the illness, the Parkinson’s Foundation said.
Currently available therapies “improve symptoms without slowing or halting the disease progression,” the foundation said.
ROCKY RELATIONS: The figures on residents come as Chinese tourist numbers drop following Beijing’s warnings to avoid traveling to Japan The number of Chinese residents in Japan has continued to rise, even as ties between the two countries have become increasingly fractious, data released on Friday showed. As of the end of December last year, the number of Chinese residents had increased by 6.5 percent from the previous year to 930,428. Chinese people accounted for 22.6 percent of all foreign residents in Japan, making them by far the largest group, Japanese Ministry of Justice data showed. Beijing has criticized Tokyo in increasingly strident terms since Japanese Prime Minister Sanae Takaichi last year suggested that a military conflict around Taiwan could
A pro-Iran hacking group claimed to breach FBI Director Kash Patel’s personal e-mail inbox and posted some of the contents online. The e-mails provided by the hacking group include travel details, correspondence with leasing agents in Washington and global entry, and loyalty account numbers. The e-mail address the hackers claim to have compromised has been previously tied to Patel’s personal details, and the leaked e-mails contain photos of Patel and others, in addition to correspondence with family members and colleagues. “The FBI is aware of malicious actors targeting Director Patel’s personal email information,” the agency said in a statement on
RIVALRY: ‘We know that these are merely symbolic investigations initiated by China, which is in fact the world’s most profligate disrupter of supply chains,’ a US official said China has started a pair of investigations into US trade practices, retaliating against similar probes by US President Donald Trump’s administration as the superpowers stake out positions before an expected presidential summit in May. The move, announced by the Chinese Ministry of Commerce on Friday, is a direct mirror of steps Trump took to revive his tariff agenda after the US Supreme Court last month struck down some of his duties. “China expresses its strong dissatisfaction and firm opposition to these actions,” a ministry spokesperson said in a statement, referring to the so-called Section 301 investigations initiated on March 11.
When a hiker fell from a 55m waterfall in wild New Zealand bush, rescuers were forced to evacuate the badly hurt woman without her dog, which could not be found. After strangers raised thousands of dollars for a search, border collie Molly was flown to safety by a helicopter pilot who was determined to reunite the pet and the owner. A week earlier, an emergency rescue helicopter found the woman with bruises and lacerations after a fall at a rocky spot at the waterfall on the South Island’s West Coast. She was airlifted on March 24, but they were forced to
RSS